Cormedix Inc (CRMD)
5.33
-0.12
(-2.20%)
USD |
NASDAQ |
Apr 24, 16:00
5.33
0.00 (0.00%)
After-Hours: 20:00
Cormedix Cash from Operations (TTM): -38.41M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -38.41M |
| September 30, 2023 | -33.82M |
| June 30, 2023 | -31.12M |
| March 31, 2023 | -28.01M |
| December 31, 2022 | -24.36M |
| September 30, 2022 | -24.07M |
| June 30, 2022 | -23.58M |
| March 31, 2022 | -21.21M |
| December 31, 2021 | -21.16M |
| September 30, 2021 | -21.22M |
| June 30, 2021 | -23.03M |
| March 31, 2021 | -20.69M |
| December 31, 2020 | -21.97M |
| September 30, 2020 | -19.92M |
| June 30, 2020 | -16.57M |
| March 31, 2020 | -15.65M |
| December 31, 2019 | -15.05M |
| September 30, 2019 | -18.37M |
| June 30, 2019 | -19.51M |
| March 31, 2019 | -24.01M |
| December 31, 2018 | -23.70M |
| September 30, 2018 | -23.78M |
| June 30, 2018 | -25.47M |
| March 31, 2018 | -28.88M |
| December 31, 2017 | -28.59M |
| Date | Value |
|---|---|
| September 30, 2017 | -27.81M |
| June 30, 2017 | -27.56M |
| March 31, 2017 | -23.57M |
| December 31, 2016 | -22.27M |
| September 30, 2016 | -19.40M |
| June 30, 2016 | -15.80M |
| March 31, 2016 | -15.63M |
| December 31, 2015 | -12.53M |
| September 30, 2015 | -10.47M |
| June 30, 2015 | -9.333M |
| March 31, 2015 | -7.240M |
| December 31, 2014 | -6.321M |
| September 30, 2014 | -5.670M |
| June 30, 2014 | -5.377M |
| March 31, 2014 | -4.430M |
| December 31, 2013 | -3.618M |
| September 30, 2013 | -3.224M |
| June 30, 2013 | -2.377M |
| March 31, 2013 | -2.764M |
| December 31, 2012 | -2.276M |
| September 30, 2012 | -2.653M |
| June 30, 2012 | -3.829M |
| March 31, 2012 | -4.707M |
| December 31, 2011 | -6.297M |
| September 30, 2011 | -6.631M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-38.41M
Minimum
Dec 2023
-15.05M
Maximum
Dec 2019
-23.04M
Average
-21.22M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| BioXcel Therapeutics Inc | -155.01M |
| Assertio Holdings Inc | 49.60M |
| Verastem Inc | -86.46M |
| Ocular Therapeutix Inc | -70.23M |
| PAVmed Inc | -52.04M |